Mekinist and Pradaxa drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Mekinist (trametinib dimethyl sulfoxide) and Pradaxa (dabigatran etexilate mesylate). Common drug interactions include asthenia among females and asthenia among males.

The phase IV clinical study analyzes what interactions people have when they take Mekinist and Pradaxa. It is created by eHealthMe based on reports of 11 people who take the same drugs from the FDA, and is updated regularly.

What is Mekinist?

Mekinist has active ingredients of trametinib dimethyl sulfoxide. eHealthMe is studying from 17,350 Mekinist users. Check the latest studies of Mekinist.

What is Pradaxa?

Pradaxa has active ingredients of dabigatran etexilate mesylate. It is often used in atrial fibrillation/flutter. eHealthMe is studying from 86,906 Pradaxa users. Check the latest studies of Pradaxa.



On Jul, 20, 2026

11 people who take Mekinist and Pradaxa together, and have interactions are studied.

Mekinist and Pradaxa drug interactions.

What are the common drug interactions of Mekinist and Pradaxa, by gender? *:

female:

  1. Asthenia (weakness)
  2. Chills (felling of cold)
  3. Dizziness
  4. Dry mouth
  5. Faeces discoloured
  6. Fatigue (feeling of tiredness)
  7. Hyperhidrosis (abnormally increased sweating)
  8. Malaise (a feeling of general discomfort or uneasiness)
  9. Nausea (feeling of having an urge to vomit)
  10. Night sweats (sweating in night)

male:

  1. Asthenia (weakness)
  2. Disease progression
  3. Pneumonia
  4. Pneumonitis (inflammation of the walls of the alveoli in the lungs)
  5. Pyrexia (fever)
  6. Renal impairment (severely reduced kidney function)
  7. Respiratory rate decreased (less breathing rate/min)
  8. Adverse reaction
  9. Blood creatine phosphokinase increased
  10. Confusional state

What are the common drug interactions of Mekinist and Pradaxa, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Disease progression
  2. Malignant melanoma (skin cancer rises from melancytes)

40-49:

n/a

50-59:

n/a

60+:

  1. Asthenia (weakness)
  2. Hypotension (abnormally low blood pressure)
  3. Autoimmune pancreatitis (autoimmune pancreatitis (aip) is an increasingly recognized type of chronic pancreatitis)
  4. Cardiac failure congestive
  5. Death
  6. Diarrhoea
  7. Dyspnoea (difficult or laboured respiration)
  8. General physical health deterioration (weak health status)
  9. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development)
  10. Myxoedema coma (coma with long untreated hypothyroidism)

What are the existing conditions these people have? *

  1. Malignant Melanoma (skin cancer rises from melancytes): 5 people, 45.45%
  2. Pulmonary Embolism (blockage of the main artery of the lung): 2 people, 18.18%
  3. Lung Neoplasm Malignant (cancer tumour of lung): 2 people, 18.18%
  4. Insomnia (sleeplessness): 2 people, 18.18%
  5. High Blood Pressure: 2 people, 18.18%
  6. Neuropathy Peripheral (surface nerve damage): 1 person, 9.09%
  7. Multiple Myeloma (cancer of the plasma cells): 1 person, 9.09%
  8. Metastatic Malignant Melanoma (spreadable cancer tumour of melanine): 1 person, 9.09%
  9. Hyperglycemia (high blood sugar): 1 person, 9.09%
  10. Herpes Simplex (herpes simplex is a common viral infection): 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Mekinist and Pradaxa?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Mekinist and Pradaxa:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Mekinist:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Pradaxa:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Mekinist and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Pradaxa and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on trametinib dimethyl sulfoxide and dabigatran etexilate mesylate (the active ingredients of Mekinist and Pradaxa, respectively), and Mekinist and Pradaxa (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: